1061 related articles for article (PubMed ID: 14506670)
81. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
82. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
83. Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein.
Otsuka H; Funai S; Tanaka A; Hara S; Shiozaki H
Lung Cancer; 2004 Sep; 45(3):307-16. PubMed ID: 15301871
[TBL] [Abstract][Full Text] [Related]
84. DNA flow cytometry of non-Hodgkin's lymphomas: correlation with cytologic grade and clinical relapse.
Saikia UN; Dey P; Vohra H; Gupta SK
Diagn Cytopathol; 2000 Mar; 22(3):152-6. PubMed ID: 10679994
[TBL] [Abstract][Full Text] [Related]
85. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.
Bergers E; Baak JP; van Diest PJ; Willig AJ; Los J; Peterse JL; Ruitenberg HM; Schapers RF; Somsen JG; van Beek MW; Bellot SM; Fijnheer J; van Gorp LH
Mod Pathol; 1997 Aug; 10(8):762-8. PubMed ID: 9267817
[TBL] [Abstract][Full Text] [Related]
86. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.
Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G
Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448
[TBL] [Abstract][Full Text] [Related]
87. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
Friberg LG; Norén H; Delle U
Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
[TBL] [Abstract][Full Text] [Related]
88. DNA content analysis of fine needle aspirates obtained from lymphatic tissue.
Alanen KA; Joensuu H; Klemi PJ
Anal Quant Cytol Histol; 1993 Aug; 15(4):259-64. PubMed ID: 8397647
[TBL] [Abstract][Full Text] [Related]
89. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract][Full Text] [Related]
90. [DNA--ploidy in non hodgkin's lymphomas of low malignancy].
Krygier-Stojałowska A; Urasiński I; Kuchnio M; Gapski Z
Acta Haematol Pol; 1993; 24(2):153-60. PubMed ID: 8372615
[TBL] [Abstract][Full Text] [Related]
91. Comparative cytophotometric analysis of reactive lymphoid hyperplasia and low malignant non-Hodgkin lymphoma.
Ruschenburg I; Peters D; Korabiowska M; Droese M
Anticancer Res; 1998; 18(3A):1613-6. PubMed ID: 9673378
[TBL] [Abstract][Full Text] [Related]
92. Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry.
Reles AE; Gee C; Schellschmidt I; Schmider A; Unger M; Friedmann W; Lichtenegger W; Press MF
Gynecol Oncol; 1998 Oct; 71(1):3-13. PubMed ID: 9784312
[TBL] [Abstract][Full Text] [Related]
93. AgNORs predictive value of prognosis in non-Hodgkin's lymphoma according to the Kiel classification.
Jakić-Razumović J; Petrovecki M; Dominis M
Mod Pathol; 1995 Feb; 8(2):143-9. PubMed ID: 7777474
[TBL] [Abstract][Full Text] [Related]
94. DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast.
Frost AR; Karcher DS; Terahata S; Siegel RS; Silverberg SG
Mod Pathol; 1996 Sep; 9(9):930-7. PubMed ID: 8878026
[TBL] [Abstract][Full Text] [Related]
95. DNA cytometry in renal cell carcinoma.
Nenning H; Rassler J; Minh DH
Gen Diagn Pathol; 1996 Mar; 141(3-4):243-7. PubMed ID: 8705789
[TBL] [Abstract][Full Text] [Related]
96. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
97. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
Grignon DJ; Abdel-Malak M; Mertens W; Koster J; Keeney M; Sakr W; Shepherd RR
Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937
[TBL] [Abstract][Full Text] [Related]
98. Flow cytometric S-phase fraction contributes to diagnosis of diploid malignant salivary gland tumours.
Driemel O; Kraft K; Hemmer J
Int J Oral Maxillofac Surg; 2006 Oct; 35(10):947-50. PubMed ID: 16829041
[TBL] [Abstract][Full Text] [Related]
99. Flow cytometry as an accurate tool to complement fine needle aspiration cytology in the diagnosis of low grade malignant lymphomas.
Schmid S; Tinguely M; Cione P; Moch H; Bode B
Cytopathology; 2011 Dec; 22(6):397-406. PubMed ID: 20735454
[TBL] [Abstract][Full Text] [Related]
100. The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
Eskelinen M; Nordling S; Puittinen J; Pesonen E; Collan Y
Pathol Res Pract; 1989 Nov; 185(5):694-7. PubMed ID: 2626377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
